ATE499371T1 - Neue kristalline formen von 2,3-dimethyl-8-(2,6- dimethylbenzylamino)-n-hydroxyethylimidazoä1,2- aüpyridin-6-carbonsäureamidmesylatsalz - Google Patents

Neue kristalline formen von 2,3-dimethyl-8-(2,6- dimethylbenzylamino)-n-hydroxyethylimidazoä1,2- aüpyridin-6-carbonsäureamidmesylatsalz

Info

Publication number
ATE499371T1
ATE499371T1 AT04809082T AT04809082T ATE499371T1 AT E499371 T1 ATE499371 T1 AT E499371T1 AT 04809082 T AT04809082 T AT 04809082T AT 04809082 T AT04809082 T AT 04809082T AT E499371 T1 ATE499371 T1 AT E499371T1
Authority
AT
Austria
Prior art keywords
carbononic
aüpyridine
dimethylbenzylamino
dimethyl
acid amide
Prior art date
Application number
AT04809082T
Other languages
English (en)
Inventor
Lars Lilljequist
Maria Lindkvist
Peter Nordberg
Ursula Pettersson
Tesfai Sebhatu
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30768770&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE499371(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE499371T1 publication Critical patent/ATE499371T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04809082T 2003-12-18 2004-12-16 Neue kristalline formen von 2,3-dimethyl-8-(2,6- dimethylbenzylamino)-n-hydroxyethylimidazoä1,2- aüpyridin-6-carbonsäureamidmesylatsalz ATE499371T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0303451A SE0303451D0 (sv) 2003-12-18 2003-12-18 New compounds
PCT/SE2004/001909 WO2005058895A1 (en) 2003-12-18 2004-12-16 Novel crystalline forms of 2, 3 dimethyl-8- (2, 6-dimethylbenzylamino) -n-hydroxyethyl-imidazo [1, 2-a] pyridine-6-carboxamide mesylate salt.

Publications (1)

Publication Number Publication Date
ATE499371T1 true ATE499371T1 (de) 2011-03-15

Family

ID=30768770

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04809082T ATE499371T1 (de) 2003-12-18 2004-12-16 Neue kristalline formen von 2,3-dimethyl-8-(2,6- dimethylbenzylamino)-n-hydroxyethylimidazoä1,2- aüpyridin-6-carbonsäureamidmesylatsalz

Country Status (24)

Country Link
US (1) US7459463B2 (de)
EP (1) EP1697360B1 (de)
JP (2) JP2007514744A (de)
KR (1) KR20060125803A (de)
CN (1) CN1894246B (de)
AR (1) AR046956A1 (de)
AT (1) ATE499371T1 (de)
AU (1) AU2004299435B2 (de)
BR (1) BRPI0417640A (de)
CA (1) CA2549144A1 (de)
CO (1) CO5721004A2 (de)
DE (1) DE602004031556D1 (de)
ES (1) ES2359829T3 (de)
IL (1) IL175957A0 (de)
MX (1) MXPA06006708A (de)
MY (1) MY140450A (de)
NO (1) NO20063309L (de)
RU (1) RU2376306C2 (de)
SE (1) SE0303451D0 (de)
TW (1) TW200526659A (de)
UA (1) UA84443C2 (de)
UY (1) UY28676A1 (de)
WO (1) WO2005058895A1 (de)
ZA (1) ZA200604633B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1682133A1 (de) * 2003-11-03 2006-07-26 AstraZeneca AB Imidazo-1,2-a-pyridin-derivate zur behandlung von beschwerdefreiem gastroösophagealem reflux
FI20086158A0 (fi) 2008-12-03 2008-12-03 Mikael Dahlstroem Imidatsopyridiinijohdannaiset
IL312564A (en) 2021-11-05 2024-07-01 Cinclus Pharma Holding Ab Publ Polymorphs of the hydrochloride salt of linfarezan glurate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4040632A1 (de) * 1990-12-19 1992-06-25 Kali Chemie Pharma Gmbh Phenylalkylaminoalkyl-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
SE9700661D0 (sv) * 1997-02-25 1997-02-25 Astra Ab New compounds
SE512531C2 (sv) * 1997-09-04 2000-03-27 Astacarotene Ab Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk förbättring av muskelfunktionsdurationen hos däggdjur och/eller behandling av muskelstörningar eller - sjukdomar hos däggdjur
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
SE0100295D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100296D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100297D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
IL157075A0 (en) * 2001-02-13 2004-02-08 Astrazeneca Ab Novel modified release formulation
EP1506016A2 (de) * 2002-05-07 2005-02-16 ALTANA Pharma AG Neue kombination von reversiblen protonenpumpenhemmern und atemwegstherapeutika zur behandlung von atemwegserkrankungen

Also Published As

Publication number Publication date
NO20063309L (no) 2006-09-14
ZA200604633B (en) 2007-04-25
EP1697360A1 (de) 2006-09-06
CN1894246A (zh) 2007-01-10
JP2012102143A (ja) 2012-05-31
CA2549144A1 (en) 2005-06-30
AR046956A1 (es) 2006-01-04
CN1894246B (zh) 2011-06-22
UA84443C2 (ru) 2008-10-27
US20070112021A1 (en) 2007-05-17
UY28676A1 (es) 2005-07-29
TW200526659A (en) 2005-08-16
US7459463B2 (en) 2008-12-02
AU2004299435B2 (en) 2008-04-17
ES2359829T3 (es) 2011-05-27
BRPI0417640A (pt) 2007-03-27
MXPA06006708A (es) 2006-08-18
CO5721004A2 (es) 2007-01-31
RU2376306C2 (ru) 2009-12-20
KR20060125803A (ko) 2006-12-06
IL175957A0 (en) 2006-10-05
SE0303451D0 (sv) 2003-12-18
WO2005058895A1 (en) 2005-06-30
DE602004031556D1 (de) 2011-04-07
EP1697360B1 (de) 2011-02-23
AU2004299435A1 (en) 2005-06-30
HK1095810A1 (en) 2007-05-18
JP2007514744A (ja) 2007-06-07
MY140450A (en) 2009-12-31
RU2006123362A (ru) 2008-01-27

Similar Documents

Publication Publication Date Title
ATE517887T1 (de) Neue 2-pyridincarbonsäureamidderivate
NO2017051I1 (no) Kariprazin, eventuelt i form av et salt, inkludert kariprazin hydroklorid
ATE551345T1 (de) Polymorphe formen des phosphatsalzes von 8-fluor- 2-ä4-ä(methylamino)methylüphenylü-1,3,4,5- tetrahydro-6h-azepinoä5,4,3-cdüindol-6-on
DE602004026576D1 (de) Verbessertes verfahren zur herstellung vom rosuvastatin calcium salz
IS7728A (is) Aðferð til að framleiða kalsíumsalt rósuvastatíns
IS8307A (is) Fenýl eða pýridýl amíð efnasambönd sem prostaglandín E2 mótlyf
DE60308596D1 (de) Verfahren zur Herstellung von anorganisichen Nanoröhren
ATE546132T1 (de) Prozess zur veränderung der kristallform von mycophenolat natrium salz
EP1933702A4 (de) Elektrodenreihe
ATE460407T1 (de) Kristalline formen von duloxetin als freie base
ATE309994T1 (de) Alkoxycarbonylaminobenzoesäure- oder alkoxycarbonylaminotetrazolylphenylderivate als ip-antagonisten
DE602005014280D1 (de) Verfahren zur herstellung von ä1,4,5ü-oxadiazepinderivaten
NO20052807D0 (no) Fremgangsmate for fremstilling av aminosyrer
DE502004009152D1 (de) Verfahren zur herstellung von derivaten des 4a,5,9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
DE60300252D1 (de) Verfahren zur industriellen Herstellung von 5-Amino-3-carboxymethyl-4-cyano-2-thiphencarboxydimethylester
ATE499371T1 (de) Neue kristalline formen von 2,3-dimethyl-8-(2,6- dimethylbenzylamino)-n-hydroxyethylimidazoä1,2- aüpyridin-6-carbonsäureamidmesylatsalz
DE60335766D1 (de) Verfahren zur Herstellung von m-Xylylendiamin
EP1637883A4 (de) Immunchromatographisches verfahren
EP1632476A4 (de) Säureadditionssalz eines carbazuckeraminderivats
EP1720840A4 (de) Verfahren zur herstellung von 1,3-dioxolannukleosiden
DE502005008620D1 (de) NEUE KRISTALLINE FORM VON 8-CYAN-1-CYCLOPROPYL-7-(1S,6S-2,8-DIAZABICYCLOi4.3.0 NONAN-8-YL)-6-FLUOR-1,4-DIHYDRO-4-OXO-3-CHINOLINCARBONSÄURE
ATE499348T1 (de) Stabiler polymorph von bifeprunoxmesilat
DE602004025752D1 (de) Verfahren zur herstellung von 4,4,4-trifluorbutan-2-on
DE502005002040D1 (de) Kontinuierliches verfahren zur herstellung von polyamiden
SE0100295D0 (sv) New compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties